...
首页> 外文期刊>Gut: Journal of the British Society of Gastroenterology >Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
【24h】

Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.

机译:比较CT结肠摄影术,结肠镜检查,乙状结肠镜检查和粪便潜血检查以检测平均风险人群中晚期腺瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIMS: This prospective trial was designed to compare the performance characteristics of five different screening tests in parallel for the detection of advanced colonic neoplasia: CT colonography (CTC), colonoscopy (OC), flexible sigmoidoscopy (FS), faecal immunochemical stool testing (FIT) and faecal occult blood testing (FOBT). METHODS: Average risk adults provided stool specimens for FOBT and FIT, and underwent same-day low-dose 64-multidetector row CTC and OC using segmentally unblinded OC as the standard of reference. Sensitivities and specificities were calculated for each single test, and for combinations of FS and stool tests. CTC radiation exposure was measured, and patient comfort levels and preferences were assessed by questionnaire. RESULTS: 221 adenomas were detected in 307 subjects who completed CTC (mean radiation dose, 4.5 mSv) and OC; 269 patients provided stool samples for both FOBT and FIT. Sensitivities of OC, CTC, FS, FIT and FOBT for advanced colonic neoplasia were 100% (95% CI 88.4% to 100%), 96.7% (82.8% to 99.9%), 83.3% (95% CI 65.3% to 94.4%), 32% (95% CI 14.9% to 53.5) and 20% (95% CI 6.8% to 40.7%), respectively. Combination of FS with FOBT or FIT led to no relevant increase in sensitivity. 12 of 45 advanced adenomas were smaller than 10 mm. 46% of patients preferred CTC and 37% preferred OC (p<0.001). CONCLUSIONS: High-resolution and low-dose CTC is feasible for colorectal cancer screening and reaches sensitivities comparable with OC for polyps >5 mm. For patients who refuse full bowel preparation and OC or CTC, FS should be preferred over stool tests. However, in cases where stool tests are performed, FIT should be recommended rather than FOBT.
机译:背景与目的:这项前瞻性试验旨在比较五个不同的并行筛查检测晚期结肠肿瘤的性能特征:CT结肠造影(CTC),结肠镜检查(OC),柔性乙状结肠镜检查(FS),粪便免疫化学粪便检测(FIT)和粪便潜血测试(FOBT)。方法:普通风险成年人提供粪便样本中的FOBT和FIT,并使用分段无盲OC作为参考标准,进行了当日低剂量64倍检测器排CTC和OC。计算每个单一测试以及FS和粪便测试的组合的敏感性和特异性。测量了CTC辐射暴露量,并通过问卷调查评估了患者的舒适度和偏好。结果:307名完成CTC(平均辐射剂量,4.5 mSv)和OC的受试者中检测到221个腺瘤; 269位患者提供了FOBT和FIT的粪便样本。 OC,CTC,FS,FIT和FOBT对晚期结肠癌的敏感性分别为100%(95%CI 88.4%至100%),96.7%(82.8%至99.9%),83.3%(95%CI 65.3%至94.4%) ),32%(95%CI 14.9%至53.5)和20%(95%CI 6.8%至40.7%)。 FS与FOBT或FIT的组合不会导致敏感性的相应提高。 45个晚期腺瘤中有12个小于10毫米。 46%的患者首选CTC,37%的患者首选OC(p <0.001)。结论:高分辨率和低剂量的四氯化碳对于大肠癌筛查是可行的,对于大于5毫米的息肉,其敏感性可与OC媲美。对于拒绝充分肠道准备和OC或CTC的患者,FS比粪便测试更可取。但是,在进行粪便测试的情况下,应推荐FIT而不是FOBT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号